Nathalie Desrosiers, Ph.D.
About Nathalie Desrosiers, Ph.D.
Nathalie Desrosiers, Ph.D., is the Head of Value, Access & Policy at BeiGene and Market Access New Product Planning - Oncology BU Lead at Novartis in Montreal, Canada. She has extensive experience in health economics, outcomes research, and market access within the pharmaceutical industry, particularly in oncology.
Current Role at BeiGene
Nathalie Desrosiers, Ph.D., currently serves as the Head of Value, Access & Policy at BeiGene in Montreal, Quebec, Canada. In this role, she oversees strategies related to health economics, value demonstration, and policy engagement. Her work focuses on optimizing patient access to innovative therapies across multiple therapeutic areas.
Novartis Responsibilities
At Novartis, Nathalie Desrosiers holds the position of Market Access New Product Planning _ Oncology BU Lead in the Montreal, Canada Area. She is responsible for devising and implementing market access strategies for new oncology products. This involves collaboration with cross-functional teams to ensure that new therapies effectively reach the patients who need them.
Previous Experience at Janssen Inc.
Nathalie Desrosiers served as the Director of Health Economics and Reimbursement_Oncology at Janssen Inc. from 2014 to 2019. During her five-year tenure, she led initiatives to develop reimbursement strategies and health economic models focusing on oncology. Her role was central to ensuring that new oncology treatments were accessible and economically viable within healthcare systems.
Educational Background
Nathalie Desrosiers has a diverse educational background, holding degrees from prestigious institutions. She studied Medical & Surgical Research/Health Economics at McGill University, Public Health at Harvard University, and Microbiology and Immunology at Université de Montréal. This broad educational foundation underpins her expertise in health policy, clinical management, and economic evaluation of healthcare interventions.
Health Economics and Outcomes Research Expertise
Nathalie Desrosiers has extensive experience in health economics and outcomes research, particularly in the oncology sector. Her previous roles include Manager Health Economics and Outcomes Research at Pfizer and Senior Manager Reimbursement at Innomar Strategies. She has consistently contributed to the development of economic models and reimbursement strategies that facilitate patient access to innovative treatments.